Products
High-Efficiency Meningococcal Vaccine Supplier in China
AIM Persistence Biopharmaceutical Co., Ltd. is the manufacturer of Meningococcal Vaccine and a reliable partner with strong R&D capabilities, making it a worthy long-term collaborator. Our vaccine provides protection against four types of infections with a single dose, effectively preventing complex infection scenarios and offering more comprehensive protection.
What is ACYW135 Meningococcal Polysaccharide Vaccine?
ACYW135 Meningococcal Polysaccharide Vaccine is a preventive biological product used to prevent epidemic cerebrospinal meningitis (referred to as "meningitis").
Its core function is to resist the invasion of Neisseria meningitidis of four serogroups A, C, Y, and W135, build a comprehensive immune protection barrier for susceptible groups, and reduce the incidence rate, severe cases and mortality of meningitis.
Hazards of Meningitis
Epidemic cerebrospinal meningitis is an acute respiratory infectious disease caused by Neisseria meningitidis, which is mainly transmitted directly through droplets such as coughing and sneezing, with patients and carriers as the source of infection.
The disease has an acute onset and rapid changes, which can lead to death within 24 hours after the onset in severe cases. Even if cured, some patients may leave sequelae such as brain damage, hearing loss and mental retardation, which are extremely harmful to human health, especially the growth and development of children and adolescents.
Core Product Information
AIM Persistence - Xin'er Cong®
Ingredients and Properties This product is made from the culture fluid of Group A, C, Y, and W135 Neisseria meningitidis, and the capsule polysaccharide antigens are extracted and purified separately, mixed, and then freeze-dried with lactose as a stabilizer. It is a white fluffy substance, and after reconstituted with the provided diluent, it becomes a colorless and clear liquid.
Active ingredients: Each human dose of this vaccine contains 50pμg of polysaccharide from Group A, C, Y, and W135 capsules.
Excipients: Each human dose contains 10.0mg of lactose.
Vaccine diluent: Sterile and pyrogen-free PBS.
Vaccination Target
At present, it is only recommended for use in high-risk populations of children over 2 years old and adults in the following scope:
1. Those who travel to or live in high-risk areas, such as the African meningitis belt (epidemic areas of Group A, C, Y, and W135 Neisseria meningitidis).
2. Those who may come into contact with Group A, C, Y, and W135 Neisseria meningitidis from the air in laboratory or vaccine production work.
3. High-risk populations in areas where the national health administrative departments predict an outbreak of Group Y and W135 Neisseria meningitidis infection based on epidemiological investigations.
Packaging specifications
| Name | Package Size(cm) | |||||
| Box Size | ||||||
| Quantity | Length | Width | Height | Volume | Weight | |
| Group ACYW135 Meningococcal Polysaccharide Vaccine | 200 | 37.8 | 22.3 | 23 | 0.02 | 4.55 |
Advantages of Xin'er Cong®
Xinercong® is a core vaccine brand under AIM Persistence Biopharmaceutical Co., Ltd. Since the launch in China, our ACYW135 Meningococcal Polysaccharide Vaccine has become a trusted preferred brand in the market with strict quality control, advanced production technology.
The core advantages are reflected in the following aspects:
● Multiple serotypes: It can prevent meningococcal meningitis caused by the four dominant serogroups A, C, Y, and W135;
● High seroconversion rate: The seroconversion rates of antibodies in the four meningococcal serogroups A, C, Y, and W135 were all over 96%;
● Long validity period: The only meningococcal product with a validity period of 36 months;
● Low residue rate: No antibiotics or any preservatives are added during the production process.
Professional and modern production workshops are the cornerstone of high-quality products!
Marketing Authorization Holder/Manufacturer: AIM Persistence Biopharmaceutical Co., Ltd.
Registered Address/Production Address: No. 29 Zhuquan Road, Science and Technology Industrial Park, Ninghai County, Ningbo City, Zhejiang Province
Contact us: If you have any further needs or inquiries, please feel free to contact us via international@aimbio.com!
- View as
ACYW135 Meningococcal Polysaccharide Vaccine
You can confidently choose the ACYW135 meningococcal polysaccharide vaccine manufactured by AIM Persistence Biopharmaceutical Co., Ltd. We are a leading vaccine manufacturer in China, with the brand name Xin'er Cong®. Our vaccine offers multiple serotypes, a high seroconversion rate, low residual levels, and a long shelf life. It contains no preservatives or antibiotics, ensuring excellent product safety!
Meningitis Vaccine
AIM Persistence Biological Pharmaceutical Co., Ltd., as a professional manufacturer, can provide you with Meningitis Vaccine. By extracting polysaccharide antigens from serogroups A, C, Y, and W135 of Neisseria meningitidis, this vaccine stimulates the body's immune system to produce specific antibodies, which can quickly recognize and eliminate the pathogens.
Vaccines for More Meningococcal Serotypes
AIM Persistence Biopharmaceutical Co., Ltd. is a professional vaccine manufacturer and supplier. We welcome you to obtain Vaccines for More Meningococcal Serotypes from us. Our Xin'er Cong® series products offer multiple serotypes, high seroconversion rates, low residual rates, and a long shelf life. We can provide a stable supply and are a reliable choice for long-term cooperation.
Meningococcal Polysaccharide Vaccine
Meningococcal Polysaccharide Vaccine is a product developed by AIM Persistence Biopharmaceutical Co., Ltd. As a reliable vaccine manufacturer, we provide a core means of preventing meningococcal meningitis, achieving a breakthrough based on conventional meningococcal polysaccharide vaccines, offering safer protection.
Meningitis Preventive Vaccine
AIM Persistence Biopharmaceutical Co., Ltd. is a professional manufacturer of Meningitis Preventive Vaccines. Vaccination with this safe and effective vaccine can prevent acute infectious diseases caused by Neisseria meningitidis, providing reliable protection, which is especially important during the high-incidence seasons of spring and winter.
W-Type Meningitis Vaccine
If you need a reliable supplier of W-Type Meningitis Vaccine, consider AIM Persistence Biopharmaceutical Co., Ltd. We are a Chinese company that develops vaccines using advanced domestic and international technologies. Our Xin'er Cong® series is an upgraded vaccine developed to address the threat of multiple serotypes of meningococcal meningitis, including W-type. It effectively prevents infection from four serotypes of meningococcal bacteria: A, C, Y, and W135 (W-type).
As a reliable Meningococcal Vaccine manufacturer and supplier in China, we have our factory. If you want to buy quality and advanced products, please contact us.
